AngioDynamics (ANGO) Q2 2026 Earnings Report

532 Followers

ANGO Q2 2026 EPS Results

Actual EPS$0.00

Consensus EPS-$0.10

Beat/MissBeat by +$0.10

One Year Ago EPS-$0.04

Actual Revenue$79.43M

Expected Revenue$76.44M

Beat/MissBeat by +$3.00M

YoY Revenue Growth+9.04%

QuarterQ2 2026

Date01/06/2026

TimeBefore Open

Conference CallTuesday, January 6, 2026

ANGO Upcoming Earnings

AngioDynamics's next earnings date is estimated for January 7, 2027, based on past reporting schedules.

ANGO Q2 2026 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Jan 07, 2027	2027 (Q2)	-0.07 / -	0	―
Oct 08, 2026	2027 (Q1)	-0.11 / -0.04	-0.1	60.00% (+0.06)
Jul 14, 2026	2026 (Q4)	-0.09 / -0.07	-0.03	-133.33% (-0.04)
Apr 02, 2026	2026 (Q3)	-0.11 / 0.02	-0.08	125.00% (+0.10)
Jan 06, 2026	2026 (Q2)	-0.10 / 0.00	-0.04	―
Oct 02, 2025	2026 (Q1)	-0.12 / -0.10	-0.11	9.09% (<+0.01)
Jul 15, 2025	2025 (Q4)	-0.12 / -0.03	-0.06	50.00% (+0.03)
Apr 02, 2025	2025 (Q3)	-0.13 / -0.08	-0.16	50.00% (+0.08)
Jan 08, 2025	2025 (Q2)	-0.11 / -0.04	-0.05	20.00% (+0.01)
Oct 03, 2024	2025 (Q1)	-0.15 / -0.11	-0.12	8.33% (<+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed